Compare SYM & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYM | RGEN |
|---|---|---|
| Founded | 2005 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 6.6B |
| IPO Year | 2021 | 1995 |
| Metric | SYM | RGEN |
|---|---|---|
| Price | $49.65 | $110.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | $62.50 | ★ $167.67 |
| AVG Volume (30 Days) | ★ 1.6M | 1.3M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | 0.03 | ★ 0.15 |
| Revenue | ★ $2,246,922,000.00 | $141,236,000.00 |
| Revenue This Year | $24.75 | $14.30 |
| Revenue Next Year | $27.90 | $14.52 |
| P/E Ratio | $1,558.17 | ★ $724.87 |
| Revenue Growth | 25.65 | ★ 35.10 |
| 52 Week Low | $26.70 | $100.99 |
| 52 Week High | $87.88 | $175.77 |
| Indicator | SYM | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 40.82 | 43.94 |
| Support Level | $49.39 | N/A |
| Resistance Level | $50.14 | $129.77 |
| Average True Range (ATR) | 3.19 | 6.03 |
| MACD | -1.04 | -1.08 |
| Stochastic Oscillator | 28.66 | 32.66 |
Symbotic Inc. is an automation technology company that develops solutions to improve operating efficiencies in modern warehouses. The group designs, commercializes, and deploys end-to-end technology systems that significantly enhance supply chain operations. The company automates the processing of pallets, cases, and individual items within warehouse environments. Its systems strengthen operations at the front end of the supply chain and provide benefits to all supply partners downstream. The company operates in two geographical regions: the United States and international markets, with the majority of its revenue generated in the United States.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.